The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Erytech Pharma; Erytech Pharma; Erytech Pharma; Erytech Pharma

TRYbeCA-1: A randomized, phase III study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).
 
Pascal Hammel
Honoraria - Celgene; Celgene; Celgene; Celgene
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Celgene; Celgene; Celgene; Celgene; ERYTECH Pharma (Inst); ERYTECH Pharma (Inst); ERYTECH Pharma (Inst); ERYTECH Pharma (Inst); Halozyme; Halozyme; Halozyme; Halozyme; Shire; Shire; Shire; Shire; VECT-HORUS; VECT-HORUS; VECT-HORUS; VECT-HORUS
Speakers' Bureau - Celgene; Celgene; Celgene; Celgene; Shire; Shire; Shire; Shire
Travel, Accommodations, Expenses - Halozyme; Halozyme; Halozyme; Halozyme; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Shire; Shire; Shire; Shire
 
Rossana Berardi
No Relationships to Disclose
 
Eric Van Cutsem
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Lilly; Lilly; Lilly; Lilly; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
Research Funding - amgen (Inst); amgen (Inst); amgen (Inst); amgen (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst)
 
Jaime Feliu
No Relationships to Disclose
 
Richard Greil
Honoraria - Abbvie; Abbvie; Abbvie; Abbvie; Amgen; Amgen; Amgen; Amgen; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Merck; Merck; Merck; Merck; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche; Sandoz; Sandoz; Sandoz; Sandoz; Takeda; Takeda; Takeda; Takeda
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Janssen; Janssen; Janssen; Janssen; Merck; Merck; Merck; Merck; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche; Takeda; Takeda; Takeda; Takeda
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); MSD (Inst); MSD (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Sandoz (Inst); Sandoz (Inst); Sandoz (Inst); Sandoz (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche
 
Harpreet Singh Wasan
Honoraria - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Celgene; Celgene; Celgene; Celgene; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Servier; Servier; Servier; Servier; Shire; Shire; Shire; Shire; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Consulting or Advisory Role - ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; Incyte; Incyte; Incyte; Incyte; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Roche Pharma AG; Roche Pharma AG; Roche Pharma AG; Roche Pharma AG; Shire; Shire; Shire; Shire; Sirtex medical; Sirtex medical; Sirtex medical; Sirtex medical
Speakers' Bureau - Celgene; Celgene; Celgene; Celgene; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; SERVIER; SERVIER; SERVIER; SERVIER; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Research Funding - Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst)
 
Jean-Philippe Metges
No Relationships to Disclose
 
Peter Nygren
No Relationships to Disclose
 
Pia J. Osterlund
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Servier/Shire; Servier/Shire; Servier/Shire; Servier/Shire
Speakers' Bureau - Prime Oncology; Prime Oncology; Prime Oncology; Prime Oncology
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); MSD (Inst); MSD (Inst); MSD (Inst); MSD (Inst); Nordic Drugs (Inst); Nordic Drugs (Inst); Nordic Drugs (Inst); Nordic Drugs (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Servier (Inst); Servier (Inst); Servier (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre
 
Marcus Smith Noel
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Celgene; Celgene; Celgene; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
Thomas Seufferlein
Honoraria - Amgen; Amgen; Amgen; Amgen; Baxalta; Baxalta; Baxalta; Baxalta; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Celgene; Celgene; Celgene; Celgene; Falk Foundation; Falk Foundation; Falk Foundation; Falk Foundation; Halozyme; Halozyme; Halozyme; Halozyme; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - Baxalta; Baxalta; Baxalta; Baxalta; Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Shire; Shire; Shire; Shire
Research Funding - Celgene; Celgene; Celgene; Celgene; Sanofi; Sanofi; Sanofi; Sanofi
Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER
 
Geert-Yan Creemers
No Relationships to Disclose
 
Anu Gupta
Employment - Erytech Pharma; Erytech Pharma; Erytech Pharma; Erytech Pharma; Synta; Synta; Synta; Synta; Vertex; Vertex; Vertex; Vertex
 
Sophie Salesse
Employment - Erytech Pharma; Erytech Pharma; Erytech Pharma; Erytech Pharma
Stock and Other Ownership Interests - Erytech Pharma; Erytech Pharma; Erytech Pharma; Erytech Pharma
 
Nigel Biswas-Baldwin
Employment - Erytech Pharma; Erytech Pharma; Erytech Pharma; Erytech Pharma
Stock and Other Ownership Interests - Erytech Pharma; Erytech Pharma; Erytech Pharma; Erytech Pharma
 
Hedy Dion
Employment - Erytech Pharma; Erytech Pharma; Erytech Pharma; Erytech Pharma
Stock and Other Ownership Interests - Erytech Pharma; Erytech Pharma; Erytech Pharma; Erytech Pharma
 
Hagop Youssoufian
No Relationships to Disclose
 
Felix Tomas Garzon
No Relationships to Disclose
 
Iman El-Hariry
Employment - Erytech Pharma; Erytech Pharma; Erytech Pharma; Erytech Pharma
Leadership - Erytech Pharma; Erytech Pharma; Erytech Pharma; Erytech Pharma
Stock and Other Ownership Interests - Erytech Pharma; Erytech Pharma; Erytech Pharma; Erytech Pharma
 
Manuel Hidalgo
Stock and Other Ownership Interests - Agenus; Agenus; Agenus; Agenus; BioOncotech; BioOncotech; BioOncotech; BioOncotech; Champions Oncology; Champions Oncology; Champions Oncology; Champions Oncology; Nelum Corp.; Nelum Corp.; Nelum Corp.; Nelum Corp.; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech
Honoraria - Agenus; Agenus; Agenus; Agenus; InxMed; InxMed; InxMed; InxMed; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Takeda; Takeda; Takeda; Takeda
Consulting or Advisory Role - Agenus; Agenus; Agenus; Agenus; Bayer; Bayer; Bayer; Bayer; Oncomatrix; Oncomatrix; Oncomatrix; Oncomatrix; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Takeda; Takeda; Takeda; Takeda
Research Funding - BiolineRx; BiolineRx; BiolineRx; BiolineRx; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma
Patents, Royalties, Other Intellectual Property - Royalties from Myriad for PALB2 patent; Royalties from Myriad for PALB2 patent; Royalties from Myriad for PALB2 patent; Royalties from Myriad for PALB2 patent
Expert Testimony - Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; BiolineRx; BiolineRx; BiolineRx; BiolineRx; Celgene; Celgene; Celgene; Celgene; Menarini; Menarini; Menarini; Menarini